Back to Studies

Study analysis · JAMA Network Open · 2024

Could a common vitamin in chicken and tuna help people with fatty liver live longer?

People with fatty liver disease who eat more niacin (vitamin B3) from food have a 30% lower risk of dying from any cause, but it doesn't seem to protect against heart disease.

Reading level
Low certainty
Level 2b · Individual cohort studyAssociation, not causationNo causal claims

Overview

What the study found

The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.

In simple terms

This study watched a big group of people with fatty liver over many years. It found that people who ate more niacin (a vitamin) lived longer on average. But this doesn't prove that niacin caused them to live longer; it only shows a link. It's like noticing that people who wear glasses read more books, but wearing glasses doesn't make you read more.

What’s the bottom line?

Researchers looked at data from over 4,000 adults with a common liver condition called NAFLD. They checked how much niacin (a B vitamin found in foods like chicken, tuna, and peanuts) people ate and followed them for about 9 years to see who died.

How strong is this study?

This study used information from a huge national health survey that includes many different kinds of people. The researchers tried to account for other factors like age and smoking, but they couldn't control everything. So the results are trustworthy for showing a link, but we can't be 100% sure that niacin is the reason people lived longer.

Reporting

0 / 100

  • COI disclosureconflicts of interest not disclosed
  • Data availabilitydata not shared
  • Code availabilitycode not shared
Methodology

38 / 100

  • Randomizationnot randomized
  • Blindingnot blinded
  • Control groupno control group
  • Sample size (n=4315)+20/20
  • Follow-up+10/10
Publication

100 / 100

Statistical

77 / 100

  • P-values+15/15
  • Effect size+20/20
  • Confidence intervals+15/15
  • Pre-registrationnot pre-registered

Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.

Where it sits

RCT reviews

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Cohort Studies
Level 2b
52

52 / 100

Probability of being correct

Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.

This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization. Despite adjustments for confounders, residual confounding and unknown confounders may exist. The study itself acknowledges it cannot establish causal relationships.

No Conflicts

No conflicts of interest identified

Not Disclosed

No conflicts of interest identified; study uses publicly available NHANES data.

Undisclosed — Suspicious

Independent Analysis Safeguards

  • Study uses publicly available data and standard statistical methods.

No conflicts of interest or funding disclosures mentioned in the provided text.

Key takeaways

  1. 01

    People who ate the most niacin (about 27 mg per day) had a 30% lower chance of dying from any cause compared to those who ate the least (about 18 mg per day).

  2. 02

    But eating more niacin did not seem to lower the risk of dying from heart disease.

  3. 03

    Yes, a 30% reduction in overall death risk is significant for individuals with NAFLD.

  4. 04

    However, because this is an observational study, we cannot be sure that niacin itself caused the benefit—other healthy habits might play a role.

Surprising findings

  • Higher niacin intake did not reduce cardiovascular mortality (the main cause of death in NAFLD) despite cutting all-cause mortality.Most people assume that a dietary change that lowers overall death risk would especially protect the heart, but this study found no significant heart benefit after full adjustment.
  • The protective association was much stronger in people with low vitamin B6 intake (74% lower risk) compared to those with adequate B6 (no significant benefit).It's unusual for a nutrient's effect to be so dependent on another nutrient, suggesting a biological synergy that few think about.

Practical takeaways

If you have NAFLD, consider increasing dietary niacin from food sources like chicken breast, tuna, peanuts, mushrooms, and fortified cereals (aim for ~27 mg/day).

This is an observational study; don't start high-dose supplements without medical advice, especially if you have diabetes or are at risk for liver toxicity from nicotinic acid.

medium confidence

Ensure adequate vitamin B6 intake (from chickpeas, fish, potatoes) as low B6 may amplify niacin's benefits, but also note that B6 alone may not be protective.

The B6 interaction needs replication; don't rely on this as a standalone recommendation.

low confidence

Why this study matters

30% Lower Mortality

Higher dietary niacin intake (≥26.7 mg/d vs ≤18.4 mg/d) was linked to a 30% reduced risk of all-cause mortality (HR 0.70; 95% CI, 0.50-0.96) in over 4,300 adults with NAFLD followed for a median of 8.8 years.

This suggests a simple dietary change—eating more niacin-rich foods—might significantly extend lifespan in a common condition affecting nearly 50% of US adults.

Why Not Heart Disease?

Despite reducing all-cause mortality, higher niacin intake did not significantly lower cardiovascular disease mortality (HR 0.65; 95% CI, 0.35-1.20), even though heart disease is the leading cause of death in NAFLD.

This challenges the assumption that what benefits overall survival always benefits heart health, and raises questions about niacin's specific mechanisms.

Niacin Works Best Without Diabetes

In non-diabetics with NAFLD, high niacin intake was linked to a 42% lower all-cause mortality risk (HR 0.58; 95% CI, 0.35-0.95), but no significant benefit was seen in those with diabetes (HR 0.82; 95% CI, 0.50-1.35).

This suggests that metabolic status strongly influences niacin's effects, and may explain conflicting results in past studies.

B6 Deficiency Makes Niacin Even More Powerful

Among those with low vitamin B6 intake (<1.7 mg/d), high niacin intake was associated with a 74% lower mortality risk (HR 0.26; 95% CI, 0.10-0.71), suggesting a synergistic interaction.

This pinpoints a specific subgroup that might benefit most, and highlights the importance of overall B vitamin status.

Want the whole report?

Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.